5.9084
price up icon1.29%   0.0884
 
loading
전일 마감가:
$5.82
열려 있는:
$5.86
하루 거래량:
100.17K
Relative Volume:
0.38
시가총액:
$461.89M
수익:
$14.02M
순이익/손실:
$-84.03M
주가수익비율:
-2.308
EPS:
-2.56
순현금흐름:
$-125.54M
1주 성능:
-11.22%
1개월 성능:
-1.59%
6개월 성능:
+7.18%
1년 성능:
+7.57%
1일 변동 폭
Value
$5.74
$6.02
1주일 범위
Value
$5.70
$6.71
52주 변동 폭
Value
$3.85
$7.60

Meiragtx Holdings Plc Stock (MGTX) Company Profile

Name
명칭
Meiragtx Holdings Plc
Name
전화
646-860-7985
Name
주소
450 EAST 29TH STREET, NEW YORK, NY
Name
직원
389
Name
트위터
@MeiraGTx
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
MGTX's Discussions on Twitter

MGTX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
MGTX 5.90 461.89M 14.02M -84.03M -125.54M -2.56
VRTX 450.44 115.43B 10.63B -479.80M -1.35B 13.33
REGN 748.45 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 590.18 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 246.35 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 106.90 24.89B 3.30B -501.07M 1.03B 11.54

Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-07-31 재개 Chardan Capital Markets Buy
2020-10-23 개시 RBC Capital Mkts Outperform
2020-09-15 재개 BofA Securities Buy
2019-09-03 개시 Piper Jaffray Overweight
2019-02-27 재확인 Chardan Capital Markets Buy
2018-07-03 개시 Barclays Overweight
2018-07-03 개시 BofA/Merrill Buy
모두보기

Meiragtx Holdings Plc 주식(MGTX)의 최신 뉴스

pulisher
Nov 20, 2024

Chardan Capital Reiterates Buy Rating for MeiraGTx (NASDAQ:MGTX) - Defense World

Nov 20, 2024
pulisher
Nov 18, 2024

Trend Tracker for (MGTX) - Stock Traders Daily

Nov 18, 2024
pulisher
Nov 15, 2024

Analysts Have Lowered Expectations For MeiraGTx Holdings plc (NASDAQ:MGTX) After Its Latest Results - Simply Wall St

Nov 15, 2024
pulisher
Nov 15, 2024

MeiraGTx Holdings plc (NASDAQ:MGTX) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Yahoo Finance

Nov 15, 2024
pulisher
Nov 15, 2024

MeiraGTx Holdings Reports Significant Losses Amid Strategic Moves - TipRanks

Nov 15, 2024
pulisher
Nov 14, 2024

MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 14, 2024
pulisher
Nov 13, 2024

MeiraGTx wins 3 Rare Pediatric designations and updates on AAV-AIPL1 - The Pharma Letter

Nov 13, 2024
pulisher
Nov 13, 2024

MeiraGTx Holdings plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 13, 2024
pulisher
Nov 13, 2024

MeiraGTx Holdings PLC Q3 2024 Earnings: Revenue Soars to $10.9M, EPS Misses Estimates at -$0.55 - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

MeiraGTx Scores Triple FDA Designations, Reports Strong Parkinson's Data Despite Q3 Loss | MGTX Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 08, 2024

Jim Cramer: This Tech Stock Is A Buy, SoFi Technologies Is Good - Benzinga

Nov 08, 2024
pulisher
Nov 08, 2024

(MGTX) Trading Signals - Stock Traders Daily

Nov 08, 2024
pulisher
Nov 01, 2024

Dynamic range: the key to MeiraGTx’s quest to control genes with pills - BioCentury

Nov 01, 2024
pulisher
Oct 29, 2024

Duchenne Muscular Dystrophy Therapeutics Market Trends, Growth Insights, and Forecasts 2033 - WhaTech

Oct 29, 2024
pulisher
Oct 29, 2024

Gene Therapy Market Detailed Analysis and Forecast to 2031 - InsightAce Analytic

Oct 29, 2024
pulisher
Oct 28, 2024

Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity - BioWorld Online

Oct 28, 2024
pulisher
Oct 22, 2024

MeiraGTx Announces Five Posters at the European Society of Gene and Cell Therapy (ESGCT) 2024 Annual Congress - The Manila Times

Oct 22, 2024
pulisher
Oct 21, 2024

High Growth Tech Stocks to Watch in October 2024 - Simply Wall St

Oct 21, 2024
pulisher
Oct 19, 2024

MeiraGTx (MGTX) Surges 14.9%: Is This an Indication of Further Gains? - MSN

Oct 19, 2024
pulisher
Oct 18, 2024

(MGTX) Long Term Investment Analysis - Stock Traders Daily

Oct 18, 2024
pulisher
Oct 17, 2024

Cell therapy weekly: US$225 million investment towards world-class research institute - RegMedNet

Oct 17, 2024
pulisher
Oct 16, 2024

MeiraGTx’s Parkinson’s gene therapy shows promise in Phase I/II study - Clinical Trials Arena

Oct 16, 2024
pulisher
Oct 16, 2024

MeiraGTx Holdings plc Inc. (MGTX) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle

Oct 16, 2024
pulisher
Oct 16, 2024

MGTX Stock Up on Upbeat Efficacy Data From Parkinson's Disease Study - Yahoo Finance

Oct 16, 2024
pulisher
Oct 16, 2024

MeiraGTx Holdings Reports Promising Parkinson’s Therapy Results - Yahoo Finance

Oct 16, 2024
pulisher
Oct 15, 2024

Items Tagged with 'glutamic acid decarboxylase' - BioWorld Online

Oct 15, 2024
pulisher
Oct 15, 2024

Items Tagged with 'AAV-GAD' - BioWorld Online

Oct 15, 2024
pulisher
Oct 15, 2024

Meiragtx looks to a phase III in Parkinson’s - BioWorld Online

Oct 15, 2024
pulisher
Oct 15, 2024

Small Cap-MeiraGTx Reveals Encouraging Data From Parkinson's Study Showing Significant, Clinically Meaningful Changes in Key Efficacy Endpoints - AOL

Oct 15, 2024
pulisher
Oct 15, 2024

MeiraGTx: Positive PD Data Moves Needle Forward For Regulatory Meetings (NASDAQ:MGTX) - Seeking Alpha

Oct 15, 2024
pulisher
Oct 15, 2024

MeiraGTx (MGTX) Sees Stock Surge After Clinical Results News - Stocks Telegraph

Oct 15, 2024
pulisher
Oct 15, 2024

MeiraGTx stock gains on Parkinson’s drug data (NASDAQ:MGTX) - Seeking Alpha

Oct 15, 2024
pulisher
Oct 15, 2024

Investors in MeiraGTx Holdings (NASDAQ:MGTX) from three years ago are still down 75%, even after 13% gain this past week - Simply Wall St

Oct 15, 2024
pulisher
Oct 15, 2024

MeiraGTx reports positive Parkinson's gene therapy trial results By Investing.com - Investing.com UK

Oct 15, 2024
pulisher
Oct 15, 2024

MeiraGTx Announces Positive Data from Randomized, Sham-controlled Clinical Bridging Study of AAV-GAD for the Treatment of Parkinson's Disease - The Manila Times

Oct 15, 2024
pulisher
Oct 15, 2024

MeiraGTx Announces Positive Data from Randomized, Sham-controlled Clinical Bridging Study of AAV-GAD for the Treatment of Parkinson’s Disease - StockTitan

Oct 15, 2024
pulisher
Oct 15, 2024

Pfizer invests in molecular glue; Jazz, MeiraGTx shares rise on drug data - Yahoo Finance

Oct 15, 2024
pulisher
Oct 12, 2024

Piper Sandler maintains Overweight rating on MeiraGTx shares - Investing.com

Oct 12, 2024
pulisher
Oct 11, 2024

Piper Sandler maintains Overweight rating on MeiraGTx shares By Investing.com - Investing.com South Africa

Oct 11, 2024
pulisher
Oct 09, 2024

MeiraGTx Announces Poster Presentation on a Potential Treatment for MC4R Genetic Deficiency at the 2024 Society for Neuroscience Conference - The Manila Times

Oct 09, 2024
pulisher
Oct 07, 2024

MeiraGTx Holdings plc's (NASDAQ:MGTX) Profit Outlook - Yahoo Finance

Oct 07, 2024
pulisher
Oct 03, 2024

DT Midstream (NYSE:DTM) Price Target Increased to $85.00 by Analysts at Barclays - Defense World

Oct 03, 2024
pulisher
Sep 30, 2024

MeiraGTx's SWOT analysis: gene therapy firm's stock faces pivotal year By Investing.com - Investing.com South Africa

Sep 30, 2024
pulisher
Sep 27, 2024

Harmony Biosciences (HRMY) Surges 6.7%: Is This an Indication of Further Gains? - Yahoo Finance

Sep 27, 2024
pulisher
Sep 25, 2024

Bank of New York Mellon Corp Sells 14,485 Shares of MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World

Sep 25, 2024
pulisher
Sep 23, 2024

Beck Capital Management LLC Has $2.07 Million Stock Holdings in Martin Marietta Materials, Inc. (NYSE:MLM) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Financial Metrics Check: Macrogenics Inc (MGNX)’s Ratios for Trailing Twelve Months - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

Leonardo Increases Stake In GEM Elettronica To 65% With EUR 16 Mln Investment - XM

Sep 23, 2024
pulisher
Sep 23, 2024

MyCelx drops as revenue guidance pushed on order delay - Proactive Investors USA

Sep 23, 2024
pulisher
Sep 22, 2024

Sei Investments Co. Decreases Stock Position in Martin Marietta Materials, Inc. (NYSE:MLM) - Defense World

Sep 22, 2024
pulisher
Sep 21, 2024

Argent Trust Co Purchases New Stake in Globus Medical, Inc. (NYSE:GMED) - Defense World

Sep 21, 2024

Meiragtx Holdings Plc (MGTX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
자본화:     |  볼륨(24시간):